DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
Documents SURGERY CASE 2 Rogelio, Graciella; Roque, Marianne; Ruanto, Teresa; Sabalvaro, Dyan Dr. Dakila Delos...

Slide 1SURGERY CASE 2 Rogelio, Graciella; Roque, Marianne; Ruanto, Teresa; Sabalvaro, Dyan Dr. Dakila Delos Angeles Slide 2 Pink is pretty but breast cancer is not! Prevention…

Documents Part Two Welcome back. Familial Cancer Genetics Cancer Genetics 5-10% of all cancer clearly linked.....

Slide 1Part Two Welcome back Slide 2 Familial Cancer Genetics Slide 3 Cancer Genetics 5-10% of all cancer clearly linked to an inherited gene alteration If cancer seen at…

Documents The ART of sparing HEART Dr. Tabassum Wadasadawala Assistant Professor, Radiation Oncology, TMC,...

Slide 1 The ART of sparing HEART Dr. Tabassum Wadasadawala Assistant Professor, Radiation Oncology, TMC, ACTREC Slide 2 Cardiac sparing techniques Use of appropriate technique…

Documents Hematology/Oncology. A 20-year-old woman of Ashkenazi Jewish descent undergoes a routine annual...

Slide 1 Hematology/Oncology Slide 2 A 20-year-old woman of Ashkenazi Jewish descent undergoes a routine annual examination. Family history includes her mother, who was diagnosed…

Documents Predictors of HER2 FISH amplification in immunohistochemistry score 2+ infiltrating breast cancer: a...

Slide 1 Predictors of HER2 FISH amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis Maria Vittoria Dieci 1, Elena Barbieri…

Documents IBIS Breast Cancer Risk Evaluation Tool. Description of buttons “Help” button activates a Word.....

Slide 1 IBIS Breast Cancer Risk Evaluation Tool Slide 2 Description of buttons “Help” button activates a Word file giving details about the program “Presentation”…

Documents 1 Study Of Letrozole Extension IBCSG 35-07/BIG 1-07 S LE.

Slide 1 1 Study Of Letrozole Extension IBCSG 35-07/BIG 1-07 S LE Slide 2 2 A phase III trial evaluating the role of continuous letrozole versus intermittent letrozole following…

Documents Friedrich Overkamp 1. GEPARQUINTO (neoadjuvant) N=30 (21+9) GEPARQUINTO (neoadjuvant) N=30 (21+9)...

Folie 1 Update 2010/2011 Friedrich Overkamp 1 Rekrutierung beendet GEPARQUINTO (neoadjuvant) N=30 (21+9) TEACH (Lapatinib adjuvant) N=8 BEATRICE (Bevacizumab adjuvant) N=15…

Documents Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort

Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohortContents lists avai Clinical characteristics and outcomes of bilateral breast cancer

Documents Anti- CANCER drugs Dr. Mohammed Abd-Almoneim. Jill liked daytime television chat shows. One morning....

Anti- CANCER drugs Anti- CANCER drugs Dr. Mohammed Abd-Almoneim   Jill liked daytime television chat shows. One morning she watched as a resident doctor explained how common…